SUBSCRIBE
SUBSCRIBE

Holly Barker

Drug Development
Merck’s Keytruda Scores Triple Hit at AACR
The checkpoint inhibitor improved patient outcomes in three cancer trials, according to results presented at the AACR meeting.
April 18, 2023
 · 
4 min read
 · 
Holly Barker